Bloodstream Infections in Children with Cancer between 2005 and 2008 in a Single Center.
- Author:
Ji Hye KIM
;
Hyung Jin KIM
;
Yeon Jung LIM
;
Young Ho LEE
;
Sung Hee OH
- Publication Type:Original Article
- Keywords:
Fever;
Neutropenia;
Neoplasms;
Bacteremia;
Catheters;
Indwelling
- MeSH:
Anti-Bacterial Agents;
Bacteremia;
Catheters;
Central Venous Catheters;
Child;
Fetal Blood;
Fever;
Fungi;
Gram-Negative Bacteria;
Gram-Positive Bacteria;
Humans;
Neutropenia;
Pediatrics;
Transplants
- From:Korean Journal of Pediatric Infectious Diseases
2010;17(1):36-48
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: In children on anticancer chemotherapy, bloodstream infections (BSIs) are a major cause of morbidity and mortality. We investigated febrile episodes and bloodstream infections in pediatric cancer patients to guide proper selection of empiric antibiotics for febrile pediatric hemato-oncologic patients. METHODS: All febrile episodes treated in the division of hematology-oncology, the department of pediatrics, Hanyang University Hospital, between July 2005 and June 2008 were reviewed. Episodes with and without bloodstream infections were compared. RESULTS: Forty cases (18.9%, 25 patients) of BSI occurred in 212 febrile episodes (63 patients). Thirty-seven cases (23.6%, 22 patients) of BSI occurred in 157 febrile episodes with neutropenia (54 patients). Microorganisms identified in BSI corresponded to 23 gram-positive bacteria (51.2%), 20 gram-negative bacteria (44.5%), and 2 fungi (4.4%). Rates of BSI between those who had received umbilical cord blood transplantation and those who had received transplantation from other source were significantly different (55.0% vs. 7.7%, P=0.001). No differences in mortality rate were observed among organisms in BSI patients. For febrile episodes the rate of BSI was higher among those with Chemoport than those with Hickman catheter (P=0.029) and gram-positive pathogens were more likely to be associated with Chemoport (P=0.001). CONCLUSION: The study showed the rate of BSI, distribution of pathogens with regard to neutropenia, transplantation, central venous catheters, and antimicrobial susceptibility of pathogens in order to help guide in the choice of optimal empiric antibiotics in pediatric febrile neutropenic hemato-oncologic patients.
